Statistics
Publications
22
Citations
1.1K
H-Index
18
Active since
2013
Zhong Xu is an author at Guizhou Provincial People's Hospital specializing in medicine, oncology, and molecular oncology.
Publications per year
2013–2023
22
22
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
Shanshan Zhang, Xinhua Song, Dan Cao et al. · Journal of Hepatology · 2017 · 185 citations · Full text
Medicine, Oncology, Pharmacology +16
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice
Jingxiao Wang, Mingjie Dong, Zhong Xu et al. · Oncogene · 2018 · 117 citations · Full text
The mTORC2‐Akt1 Cascade Is Crucial for c‐Myc to Promote Hepatocarcinogenesis in Mice and Humans
Zhong Xu, Meng Xu, Liu Pin et al. · Hepatology · 2019 · 100 citations · Full text
Medicine, Cell Biology, Oncology +15
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans
Biao Fan, Maria G. Pilo, Zhong Xu et al. · Oncogenesis · 2016 · 74 citations · Full text
1–5 of 22